
Syndax Pharmaceuticals, a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced the appointment of Daphne Karydas as Chief Financial Officer, effective July 13, 2020. Karydas brings to Syndax nearly 20 years of financial experience in the biopharmaceutical industry. Prior to this role, Daphne served as Senior Vice President of Corporate Financial…